Know the sample is right before the biopsy ends.
ROSE Diagnostics is developing a rapid 5-minute test that checks biopsy specimens during the procedure, so patients aren't called back for a repeat biopsy and can start treatment sooner.
*Products not FDA cleared or approved in any jurisdiction
The problem
Up to
of lung biopsy samples are returned as insufficient for analysis
About
new lung cancer cases expected in the U.S. in 2026
About
U.S. lung cancer deaths expected in 2026, more than any other cancer
Source: American Cancer Society, Cancer Facts & Figures 2026
One biopsy, not two.
Testing the specimen in the procedure room removes the wait, and the repeat visit.
Today
- 1Biopsy performed
- 2Sample sent to pathology lab
- 3Waiting for results
- !Up to 40% insufficient
- ↻Patient returns for repeat biopsy
With verifi LUNG test
- 1Biopsy performed
- 25-minute cartridge test in the room
- 3Specimen confirmed before the procedure ends
- ✓Sample to lab, on to diagnosis
The solution
The verifi LUNG test checks the biopsy specimen in the procedure room, so the care team knows the sample is sufficient before the patient goes home.
Answers: up to 40% insufficient samples
Verified in 5 minutes
A rapid point-of-care test confirms the specimen during the biopsy, while there's still time to collect more tissue if needed.
Answers: 229,000 new cases a year
Built for every procedure room
Disposable test cartridges run on a small, affordable, portable reader that is already approved for other diagnostic products.
Answers: 125,000 lives lost a year
A faster path to treatment
Getting the sample right the first time means fewer repeat biopsies, less waiting and anxiety for patients, and treatment that can start sooner.
*Products not FDA cleared or approved in any jurisdiction